Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy

Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy

Background: Intact immune responses to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) represent a biologically and clinically relevant correlate of ‘immunological fitness’ in humans. However, there is a lack of knowledge concerning anti-EBV or anti-CMV responses in patients with pulmonary tuberc...

Full description

Bibliographic Details
Main Authors: Tumaini Nagu, Said Aboud, Martin Rao, Mecky Matee, Rebecca Axelsson, Davide Valentini, Ferdinand Mugusi, Alimuddin Zumla, Markus Maeurer
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:International Journal of Infectious Diseases
Subjects:
pulmonary tuberculosis
EBV
CMV
cellular immune response
IFN-γ
survival
TB therapy,
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971217300255

Internet

http://www.sciencedirect.com/science/article/pii/S1201971217300255

Similar Items